Abstract:Using published studies, pharmacophore groups of anti‐inflammatory agents with 1,3,4‐oxadiazole and 1,2,4‐triazole nuclei were determined. Docking studies of identified pharmacophore groups on inducible nitric oxide synthase (iNOS) were performed to identify potent derivatives. New 1,3,4‐oxadiazoles (3a–f, 4a–f) and their cyclized 1,2,4‐triazolo[3,4‐b][1,3,4]thiadiazine derivatives (5a–e, 6a–e) were designed and synthesized as anti‐inflammatory agents targeting iNOS, prostaglandin E2 (PGE2), and interleukin‐6 (IL‐6). Due to the serious gastrointestinal side effects associated with prolonged use of current anti‐inflammatory therapies, various strategies such as the regulation of nitric oxide (NO) and prostaglandin E2 (PGE2) production have been explored in the field of anti‐inflammatory drug development. In this study, a series of disubstituted 1,3,4‐oxadiazoles (3a–f and 4a–f) and their cyclized 1,2,4‐triazole derivatives (5a–e and 6a–e) were synthesized and tested for their NO, PGE2, and interleukin‐6 (IL‐6) releasing inhibition ability. All of the compounds were observed to reduce lipopolysaccharide (LPS)‐induced nitrite production in a concentration‐dependent manner. Moreover, compounds 3b (50 μM) and 6d (1 μM) exhibited 63% and 49% inhibition, respectively, while indomethacin showed 52% at 100 μM. Based on a preliminary NO inhibition assay, 10 of the compounds (3a, 3b, 3e, 4b, 4d, 6a–e) were selected to be evaluated for in vitro PGE2, IL‐6, and inducible nitric oxide synthase (iNOS) inhibition. Notably, compound 6d proved to be the most active of the series with the lowest dose (1 μM), in comparison to the other further tested compounds (5–100 μM) and the reference drug indomethacin (100 μM). The inhibitory activity of the compounds was supported by docking simulations into the binding site of the iNOS protein receptor (Protein Data Bank [PDB]ID: 3E7G). The data showing that 4d reduced iNOS levels the most can be explained by the H‐bond with Tyr347 through oxadiazole and π–halogen interactions through the p‐bromo, in addition to aromatic interactions with protoporphyrin IX.

Phosphatidyl myo-inositol mannosides mimics built on an acyclic or heterocyclic core: synthesis and anti-inflammatory properties.

Mycobacterial Phosphatidylinositol Mannosides Negatively Regulate Host Toll-like Receptor 4, MyD88-dependent Proinflammatory Cytokines, and TRIF-dependent Co-stimulatory Molecule Expression

Detergent-induced quantitatively limited formation of diacyl phosphatidylinositol dimannoside in Mycobacterium smegmatis

Novel amides of mycophenolic acid and some heterocyclic derivatives as immunosuppressive agents

Production and Purification of Phosphatidylinositol Mannosides from Mycobacterium smegmatis Biomass

Design of Group IIA Secreted/Synovial Phospholipase A2 Inhibitors: an Oxadiazolone Derivative Suppresses Chondrocyte Prostaglandin E2 Secretion

A New N-Substituted 1 H-Isoindole-1,3(2 H)-Dione Derivative-Synthesis, Structure and Affinity for Cyclooxygenase Based on In Vitro Studies and Molecular Docking

PEPITEM Tripeptides and Peptidomimetics: Next-Generation Modulators of Inflammation in Immune-Mediated Conditions

iNOS/PGE2 inhibitors as a novel template for analgesic/anti‐inflammatory activity: Design, synthesis, in vitro biological activity and docking studies

Structural Exploration, Synthesis and Pharmacological Evaluation of Novel 5-Benzylidenethiazolidine-2,4-dione Derivatives As Inos Inhibitors Against Inflammatory Diseases

Exploring new imines as anti-inflammatory COX and 5-LOX inhibitors with an improved pharmacokinetic profile

Indole Derivatives Bearing Imidazole, Benzothiazole-2-Thione or Benzoxazole-2-Thione Moieties—Synthesis, Structure and Evaluation of Their Cytoprotective, Antioxidant, Antibacterial and Fungicidal Activities

Synthesis, antimycobacterial activity and influence on mycobacterial InhA and PknB of 12-membered cyclodepsipeptides.

Natural Polyketides Isolated from the Endophytic Fungus Phomopsis sp. CAM212 with a Semisynthetic Derivative Downregulating the ERK/IκBα Signaling Pathways

Synthesis And Biological Evaluation Of Novel Membrane-Permeant Cyclic Adp-Ribose Mimics: N-1-[(5 ''-O-Phosphorylethoxy)Methyl]-5 '-O-Phosphorylinosine 5 ',5 ''-Cyclicpyrophosphate (Cidpre) And 8-Substituted Derivatives

Polysaccharide Mycophenolate-Based Nanoparticles for Enhanced Immunosuppression and Treatment of Immune-Mediated Inflammatory Diseases

Synthesis and biological evaluation of novel 5-benzylidenethiazolidine-2,4-dione derivatives for the treatment of inflammatory diseases.

(E)-1,3-diphenyl-1h-pyrazole Derivatives Containing O-benzyl Oxime Moiety As Potential Immunosuppressive Agents: Design, Synthesis, Molecular Docking and Biological Evaluation.

Functions, Mechanisms, and therapeutic applications of the inositol pyrophosphates 5PP-InsP5 and InsP8 in mammalian cells

Cellular Effects and Metabolic Stability of N1-cyclic Inosine Diphosphoribose and Its Derivatives.

Synthesis and Biological Activity of New Phthalimides As Potential Anti-Inflammatory Agents